Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
53.59 USD | +1.17% | -1.07% | +1.61% |
01/05 | Transcript : Essent Group Ltd. - Shareholder/Analyst Call | |
04/04 | Keefe Buyette & Woods Raises Essent Group's Price Target to $64 From $62, Maintains Market Perform Rating | MT |
Strengths
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Its low valuation, with P/E ratio at 8.04 and 7.49 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company appears to be poorly valued given its net asset value.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Property & Casualty Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+1.61% | 5.65B | B- | ||
+42.99% | 62.62B | B- | ||
+11.90% | 50.76B | C+ | ||
+11.90% | 48.58B | B | ||
+22.56% | 44.85B | B- | ||
+28.99% | 34.96B | B- | ||
+12.27% | 29.37B | B- | ||
+52.27% | 28.66B | B | ||
+25.02% | 24.85B | C- | ||
+9.98% | 20.64B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ESNT Stock
- Ratings Essent Group Ltd.